Woodward DF[au] - Search Results

Year	Number of Results
1980	3
1981	1
1982	2
1983	6
1984	3
1985	6
1986	6
1987	3
1988	2
1989	6
1990	4
1991	3
1992	1
1993	5
1994	6
1995	11
1996	3
1997	9
1998	4
2000	4
2001	6
2002	3
2003	3
2004	7
2005	5
2006	6
2007	9
2008	6
2009	4
2010	8
2011	5
2012	4
2013	7
2014	2
2015	3
2016	5
2017	2
2018	2
2019	5
2020	4
2021	1

1

Antiglaucoma EP₂ Agonists: A Long Road That Led Somewhere.

Woodward DF, Wang JW, Stamer WD, Lütjen-Drecoll E, Krauss AH, Toris CB. Woodward DF, et al. J Ocul Pharmacol Ther. 2019 Nov;35(9):469-474. doi: 10.1089/jop.2019.0041. Epub 2019 Jul 19. J Ocul Pharmacol Ther. 2019. PMID: 31329508 Review.

2

Effect of the Antiglaucoma Agent JV-GL1 and Related Compounds in the Canine Eye.

Woodward DF, Coleman RA, Woodrooffe AJ, Spada CS, Wang JW. Woodward DF, et al. J Ocul Pharmacol Ther. 2020 Oct;36(8):636-648. doi: 10.1089/jop.2020.0033. Epub 2020 Jul 8. J Ocul Pharmacol Ther. 2020. PMID: 32640926

3

A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes.

Woodward DF, Wang JW, Spada CS, Carling RW, Martos JL, Pettit S, Kangasmetsa J, Waterbury LD, Lawrence M, Hu W, Poloso NJ. Woodward DF, et al. ACS Pharmacol Transl Sci. 2020 Oct 26;3(6):1199-1210. doi: 10.1021/acsptsci.0c00118. eCollection 2020 Dec 11. ACS Pharmacol Transl Sci. 2020. PMID: 33344897

4

A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method.

Woodward DF, Wang JW, Coleman RA, Woodrooffe AJ, Clark KL, Stamer WD, Tao G, Fan S, Toris CB. Woodward DF, et al. J Ocul Pharmacol Ther. 2019 Jun;35(5):265-277. doi: 10.1089/jop.2018.0126. Epub 2019 Apr 25. J Ocul Pharmacol Ther. 2019. PMID: 31025909

5

The role of EP₂ receptors in mediating the ultra-long-lasting intraocular pressure reduction by JV-GL1.

Bertrand JA, Woodward DF, Sherwood JM, Wang JW, Overby DR. Bertrand JA, et al. Among authors: woodward df. Br J Ophthalmol. 2020 Nov 25:bjophthalmol-2020-317762. doi: 10.1136/bjophthalmol-2020-317762. Online ahead of print. Br J Ophthalmol. 2020. PMID: 33239414

6

Distribution and Function of Prostaglandin E₂ Receptors in Mouse Uterus: Translational Value for Human Reproduction.

Fischer DP, Griffiths AL, Lui S, Sabar UJ, Farrar D, O'Donovan PJ, Woodward DF, Marshall KM. Fischer DP, et al. Among authors: woodward df. J Pharmacol Exp Ther. 2020 Jun;373(3):381-390. doi: 10.1124/jpet.119.263509. Epub 2020 Mar 23. J Pharmacol Exp Ther. 2020. PMID: 32205366

7

The affinity, intrinsic activity and selectivity of a structurally novel EP₂ receptor agonist at human prostanoid receptors.

Coleman RA, Woodrooffe AJ, Clark KL, Toris CB, Fan S, Wang JW, Woodward DF. Coleman RA, et al. Among authors: woodward df. Br J Pharmacol. 2019 Mar;176(5):687-698. doi: 10.1111/bph.14525. Epub 2019 Jan 4. Br J Pharmacol. 2019. PMID: 30341781 Free PMC article.

8

Prostamides (prostaglandin-ethanolamides) and their pharmacology.

Woodward DF, Liang Y, Krauss AH. Woodward DF, et al. Br J Pharmacol. 2008 Feb;153(3):410-9. doi: 10.1038/sj.bjp.0707434. Epub 2007 Aug 27. Br J Pharmacol. 2008. PMID: 17721551 Free PMC article. Review.

9

Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases.

Urquhart P, Nicolaou A, Woodward DF. Urquhart P, et al. Among authors: woodward df. Biochim Biophys Acta. 2015 Apr;1851(4):366-76. doi: 10.1016/j.bbalip.2014.12.015. Epub 2014 Dec 24. Biochim Biophys Acta. 2015. PMID: 25543004 Review.

10

Fixed-combination and emerging glaucoma therapies.

Woodward DF, Chen J. Woodward DF, et al. Expert Opin Emerg Drugs. 2007 May;12(2):313-27. doi: 10.1517/14728214.12.2.313. Expert Opin Emerg Drugs. 2007. PMID: 17604504 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results